Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (611-620 of 799) with videos related to

Pageof 80
Sort By:
Breast Cancer Research and Treatment|June 7, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancerRoberto A Leon-Ferre, Edith A Perez, David W Hillman, et al.
Medrxiv : the Preprint Server for Health Sciences|October 31, 2023
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survivalLinda Kachuri, Geno A Guerra, George A Wendt, et al.
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Journal of Neuropathology and Experimental Neurology|February 7, 2021
Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 YearsAmber L Pryzbylski, Thomas M Kollmeyer, Corinne E Praska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDHJ Gregory Cairncross, Meihua Wang, Robert B Jenkins, et al.
Breast Cancer Research and Treatment|January 8, 2014
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring studyAnn E McCullough, Patrizia Dell'orto, Monica M Reinholz, et al.
Neuro-Oncology|June 20, 2012
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Brett L Carlson, Mark A Schroeder, et al.
The New England Journal of Medicine|January 14, 1999
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancerL C Hartmann, D J Schaid, J E Woods, et al.
American Journal of Human Genetics|May 13, 2022
The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survivalGeno Guerra, Linda Kachuri, George Wendt, et al.
Nature Communications|January 14, 2025
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survivalLinda Kachuri, Geno A Guerra, Taishi Nakase, et al.
Pageof 80

Showing results (611-620 of 799) with videos related to

Sort By:
Pageof 80
Breast Cancer Research and Treatment|June 7, 2020
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancerRoberto A Leon-Ferre, Edith A Perez, David W Hillman, et al.
Medrxiv : the Preprint Server for Health Sciences|October 31, 2023
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survivalLinda Kachuri, Geno A Guerra, George A Wendt, et al.
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Journal of Neuropathology and Experimental Neurology|February 7, 2021
Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 YearsAmber L Pryzbylski, Thomas M Kollmeyer, Corinne E Praska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDHJ Gregory Cairncross, Meihua Wang, Robert B Jenkins, et al.
Breast Cancer Research and Treatment|January 8, 2014
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring studyAnn E McCullough, Patrizia Dell'orto, Monica M Reinholz, et al.
Neuro-Oncology|June 20, 2012
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Brett L Carlson, Mark A Schroeder, et al.
The New England Journal of Medicine|January 14, 1999
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancerL C Hartmann, D J Schaid, J E Woods, et al.
American Journal of Human Genetics|May 13, 2022
The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survivalGeno Guerra, Linda Kachuri, George Wendt, et al.
Nature Communications|January 14, 2025
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survivalLinda Kachuri, Geno A Guerra, Taishi Nakase, et al.
Pageof 80